Prabha Sarangi

Prabha Sarangi is a highly experienced research professional currently serving as a Senior Research Investigator at Biohaven since February 2024. Prior to this, Prabha held the position of Senior Scientist at RADD Pharmaceuticals from June 2021 to December 2023, where Prabha developed and executed cellular and biochemical assays while utilizing advanced cell biological techniques to enhance the understanding of target and disease biology. Prabha's earlier experience includes a role as a Postdoctoral Research Fellow at Dana-Farber Cancer Institute from February 2015 to June 2021, focusing on genome stability pathways and establishing TRIP13 as a prognostic biomarker in BRCA-deficient cancers. Prabha earned a PhD in Molecular Biology from Weill Cornell Graduate School of Medical Sciences and a Bachelor of Technology in Biotechnology from Indian Institute of Technology, Madras.